Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Novo Nordisk A/S ADR (NVO)

Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 573,775,872
  • Shares Outstanding, K 4,487,532
  • Annual Sales, $ 33,724 M
  • Annual Income, $ 12,151 M
  • 60-Month Beta 0.41
  • Price/Sales 17.52
  • Price/Cash Flow 44.26
  • Price/Book 41.53
Trade NVO with:

Options Overview Details

View History
  • Implied Volatility 38.78% ( +1.89%)
  • Historical Volatility 28.34%
  • IV Percentile 96%
  • IV Rank 72.40%
  • IV High 44.88% on 08/03/23
  • IV Low 22.77% on 08/11/23
  • Put/Call Vol Ratio 0.87
  • Today's Volume 18,027
  • Volume Avg (30-Day) 21,905
  • Put/Call OI Ratio 0.65
  • Today's Open Interest 252,734
  • Open Int (30-Day) 256,386

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.76
  • Number of Estimates 5
  • High Estimate 0.85
  • Low Estimate 0.67
  • Prior Year 0.63
  • Growth Rate Est. (year over year) +20.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
126.35 +0.30%
on 07/25/24
145.99 -13.19%
on 07/01/24
-16.94 (-11.79%)
since 06/26/24
3-Month
121.29 +4.48%
on 05/03/24
148.15 -14.46%
on 06/25/24
-0.12 (-0.09%)
since 04/26/24
52-Week
77.96 +62.57%
on 07/28/23
148.15 -14.46%
on 06/25/24
+47.59 (+60.13%)
since 07/26/23

Most Recent Stories

More News
Why Weight Loss Drug Developer Stocks Tumbled on Thursday

Companies like Novo Nordisk and Eli Lilly might soon have a determined competitor in their hottest product category.

VKTX : 65.98 (+2.01%)
RHHBY : 40.7600 (+3.03%)
NVO : 126.73 (-0.88%)
LLY : 804.62 (-2.02%)
Beware, Wegovy -- Pfizer Is Working on a Competitor

Pfizer wants to maintain its recent run of key approvals.

PFE : 30.77 (+3.39%)
NVO : 126.73 (-0.88%)
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?

Roche might give Lilly and Novo Nordisk a run for their money -- sometime down the road.

NVO : 126.73 (-0.88%)
LLY : 804.62 (-2.02%)
RHHBY : 40.7600 (+3.03%)
Here's My Top Growth Stock to Buy Right Now

Hims & Hers shares have multi-bagger growth potential over the years to come.

NVO : 126.73 (-0.88%)
HIMS : 21.77 (-6.37%)
3 Monster Stocks in the Making to Buy Right Now

They're small now, but these stocks could grow much larger.

VRTX : 495.26 (+0.61%)
NVO : 126.73 (-0.88%)
ZLDPF : 129.2424 (-4.73%)
CRSP : 57.92 (+0.61%)
VKTX : 65.98 (+2.01%)
Is Viking Therapeutics a Millionaire-Maker?

This biotech stock fits the profile of a potentially big winner to a T.

LLY : 804.62 (-2.02%)
NVO : 126.73 (-0.88%)
VKTX : 65.98 (+2.01%)
Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped

Roche has a new GLP-1 weight loss drug in the works -- and one very cheap stock.

RHHBY : 40.7600 (+3.03%)
LLY : 804.62 (-2.02%)
NVO : 126.73 (-0.88%)
Is Viking Therapeutics the Best Biotech Stock for You?

Let's look beyond the hype the company is generating this year.

LLY : 804.62 (-2.02%)
VKTX : 65.98 (+2.01%)
NVO : 126.73 (-0.88%)
1 Big Pharma Dividend Stock to Snag While It's Still Cheap

Pfizer's stock presents a compelling investment opportunity, trading at an attractive valuation with a high dividend yield, as the company makes promising progress on its oral obesity drug, danuglipron,...

PFE : 30.77 (+3.39%)
NVO : 126.73 (-0.88%)
LLY : 804.62 (-2.02%)
BLK : 856.20 (+2.35%)
STT : 85.29 (+0.47%)
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split

Revenue is climbing at these two drug companies -- and the trend should continue.

WMT : 69.78 (-0.34%)
CMG : 49.83 (-1.95%)
NVO : 126.73 (-0.88%)
NVDA : 113.06 (+0.69%)
REGN : 1,078.63 (+1.36%)
BIIB : 211.17 (-7.15%)
AMGN : 334.85 (+0.16%)
LLY : 804.62 (-2.02%)
VRTX : 495.26 (+0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Bagsv'rd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity.Novo Nordisk operates through two segments: Diabetes and obesity care...

See More

Key Turning Points

3rd Resistance Point 129.77
2nd Resistance Point 129.02
1st Resistance Point 127.87
Last Price 126.73
1st Support Level 125.97
2nd Support Level 125.22
3rd Support Level 124.07

See More

52-Week High 148.15
Last Price 126.73
Fibonacci 61.8% 121.34
Fibonacci 50% 113.05
Fibonacci 38.2% 104.77
52-Week Low 77.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar